What is the appropriate treatment for a large, circular, itchy, and well-circumscribed plaque accompanied by xerosis on the posterior heel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Large Circular Itchy Plaque with Xerosis on Posterior Heel

For a large, circular, itchy, well-circumscribed plaque with xerosis on the posterior heel, initiate treatment with a moderate-to-high potency topical corticosteroid (class 2-5) combined with urea 10% cream applied twice to three times daily, while addressing any underlying mechanical stress factors. 1, 2

Primary Treatment Approach

Topical Corticosteroid Therapy

  • Apply a moderate-to-high potency topical corticosteroid (class 2-5) twice daily for up to 4 weeks maximum to the well-circumscribed plaque, as this presentation is consistent with localized psoriasis or eczematous dermatitis 1
  • The posterior heel location tolerates higher potency steroids better than intertriginous or facial areas, allowing for more aggressive initial treatment 1
  • Avoid ultra-high potency steroids (class 1) unless under dermatological supervision due to risk of skin atrophy, particularly important given the xerosis already present 1

Xerosis Management

  • Apply urea 10% cream three times daily to address the xerosis component, which is FDA-approved for hyperkeratotic conditions including dry, rough skin, dermatitis, psoriasis, and xerosis 2
  • Urea acts as both a humectant and keratolytic agent, promoting normal healing of hyperkeratotic surface lesions 2
  • The combination of emollient therapy with corticosteroids enhances overall efficacy and prevents the dry, cracked skin that perpetuates the itch-scratch cycle 3, 4

Mechanical Stress Reduction

Critical Behavioral Modifications

  • Avoid mechanical stress to the heel: no prolonged walking, ensure cushioned shoes with proper heel support, and avoid barefoot walking 5
  • The posterior heel is particularly susceptible to friction and pressure, which can trigger Koebnerization (trauma-induced lesion formation) in psoriasis 5
  • Avoid chemical stress from skin irritants, solvents, or disinfectants that could worsen the condition 5

Treatment Algorithm

Week 0-2: Initial Phase

  • Moderate-to-high potency topical corticosteroid twice daily 1
  • Urea 10% cream three times daily 2
  • Implement mechanical stress avoidance strategies 5
  • Reassess after 2 weeks for improvement 5

Week 2-4: Continuation or Escalation

  • If improving: Continue current regimen until complete clearance, but do not exceed 4 weeks of continuous corticosteroid use 1
  • If no improvement or worsening: Consider adding vitamin D analog (calcipotriene) to the corticosteroid for synergistic effect, or refer to dermatology 1
  • The well-circumscribed, hypertrophic nature suggests possible treatment resistance requiring specialist evaluation 5

Week 4+: Maintenance Phase

  • Transition to weekend-only corticosteroid application while continuing urea cream daily to prevent relapse 1
  • Consider vitamin D analog (calcipotriene) on weekdays as steroid-sparing maintenance 1

Important Clinical Considerations

Differential Diagnosis Implications

  • The circular, well-circumscribed plaque pattern on the posterior heel strongly suggests localized plaque psoriasis, though eczematous dermatitis or lichen simplex chronicus remain possibilities 5, 1
  • Repetitive scratching from pruritus can create fixed, hypertrophic plaques through Koebnerization, making the lesion more treatment-resistant 5
  • Xerosis is both a contributing factor and consequence of the inflammatory process, requiring simultaneous treatment 6, 4

Common Pitfalls to Avoid

  • Do not prescribe refills without clinical reassessment, as prolonged corticosteroid use can cause skin atrophy, particularly concerning given pre-existing xerosis 1
  • Do not exceed 100g of moderate potency corticosteroid per month 1
  • Avoid systemic corticosteroids entirely, as they can precipitate severe psoriasis flares upon discontinuation 1, 7
  • Patient-perceived "treatment failure" is often due to poor adherence rather than true resistance; ensure clear application instructions 5

When to Refer to Dermatology

  • Lack of improvement after 6 weeks of appropriate topical therapy 5
  • Lesion extends beyond localized area or new lesions develop elsewhere 1
  • Severe hyperkeratosis requiring more aggressive keratolytic therapy 5
  • Need for systemic therapy consideration if topical treatment fails 1

Adjunctive Pruritus Management

If Pruritus Persists Despite Treatment

  • Consider adding topical doxepin for up to 8 days (limited to <10% body surface area) for severe itch 5
  • Topical clobetasone butyrate (moderate-potency steroid) or menthol-containing preparations may provide additional antipruritic benefit 5
  • Avoid topical antihistamines long-term due to limited efficacy and potential for contact sensitization 5

References

Guideline

Management of Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Xerosis: a dysfunction of the epidermal barrier].

Actas dermo-sifiliograficas, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Non-Plaque Psoriasis Subtypes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.